Income Statement Virbac

Equities

VIRP

FR0000031577

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:37:42 2025-06-20 am EDT			5-day change	1st Jan Change
323.50 ^EUR	+0.15%		+1.73%	+2.21%

Jun. 19	France's Virbac Names New CEO	MT
Jun. 19	Virbac: new CEO from early September	CF

7.oIi64cOmG-9sHaHMExCLYDEOlD2DxPfJ7LfwmHU9FA8.l-rvlvTLVLoKUc74I3rCGEhUxXflgpn4ouLI9TkOUH3B5NGtlcNz3QFI0g

Published financial data: VIRBAC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	934M	1.06B	1.22B	1.25B	1.4B
Total Revenues	934M	1.06B	1.22B	1.25B	1.4B
Cost of Goods Sold, Total	317M	351M	421M	434M	456M
Gross Profit	618M	713M	795M	813M	941M
Selling General & Admin Expenses, Total	437M	495M	557M	573M	645M
Depreciation & Amortization - (IS)	40.22M	38.02M	42.21M	45.49M	52.05M
Amortization of Goodwill and Intangible Assets - (IS)	8.38M	4.31M	3.74M	3.26M	4.32M
Other Operating Expenses	8.09M	5.09M	7.92M	5.19M	10.42M
Other Operating Expenses, Total	494M	542M	611M	627M	712M
Operating Income	124M	171M	184M	186M	229M
Interest Expense, Total	-10.72M	-5.98M	-3.69M	-8.88M	-11.12M
Interest And Investment Income	2.02M	2.37M	4.83M	8.72M	6.39M
Net Interest Expenses	-8.7M	-3.61M	1.14M	-158K	-4.73M
Income (Loss) On Equity Invest.	306K	196K	525K	455K	467K
Currency Exchange Gains (Loss)	-433K	-4.73M	-4.08M	-10.1M	-4.97M
Other Non Operating Income (Expenses)	-1.29M	-177K	-140K	413K	417K
EBT, Excl. Unusual Items	114M	163M	181M	177M	220M
Restructuring Charges	-	-	-	-997K	-1.86M
Merger & Related Restructuring Charges	-	-	-	-	-8.12M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-3.18M	-3.64M	-473K	-2.05M	-2.39M
Asset Writedown	-4.5M	642K	-3.69M	836K	860K
Other Unusual Items	69.64M	-219K	-	119K	-439K
EBT, Incl. Unusual Items	176M	159M	177M	175M	208M
Income Tax Expense	33.77M	43.61M	55.65M	53.52M	62.48M
Earnings From Continuing Operations	142M	116M	121M	121M	146M
Net Income to Company	142M	116M	121M	121M	146M
Minority Interest	-4.3M	-2.53M	648K	210K	-492K
Net Income - (IS)	137M	113M	122M	121M	145M
Net Income to Common Incl Extra Items	137M	113M	122M	121M	145M
Net Income to Common Excl. Extra Items	137M	113M	122M	121M	145M
Per Share Items
Net EPS - Basic	16.29	13.4	14.44	14.4	17.35
Basic EPS - Continuing Operations	16.29	13.4	14.44	14.4	17.35
Basic Weighted Average Shares Outstanding	8.44M	8.45M	8.45M	8.42M	8.37M
Net EPS - Diluted	16.29	13.4	14.43	14.38	17.34
Diluted EPS - Continuing Operations	16.29	13.4	14.43	14.38	17.34
Diluted Weighted Average Shares Outstanding	8.44M	8.45M	8.45M	8.44M	8.38M
Normalized Basic EPS	7.9	11.72	13.48	13.14	16.38
Normalized Diluted EPS	7.9	11.72	13.47	13.11	16.37
Dividend Per Share	0.75	1.25	1.32	1.32	1.45
Payout Ratio	-	5.61	8.67	9.2	7.61
Supplemental Items
EBITDA	161M	204M	218M	222M	274M
EBITA	137M	180M	193M	196M	241M
EBIT	124M	171M	184M	186M	229M
EBITDAR	163M	206M	222M	226M	279M
Effective Tax Rate - (Ratio)	19.24	27.38	31.45	30.65	30
Current Domestic Taxes	9.4M	16.28M	14.74M	7.14M	19.06M
Current Foreign Taxes	27.66M	36.4M	46.67M	44.69M	48M
Total Current Taxes	37.06M	52.67M	61.41M	51.84M	67.06M
Deferred Domestic Taxes	-815K	-5.45M	-130K	5.42M	198K
Deferred Foreign Taxes	-2.47M	-3.61M	-5.63M	-3.74M	-4.78M
Total Deferred Taxes	-3.28M	-9.06M	-5.76M	1.68M	-4.58M
Normalized Net Income	66.68M	99.04M	114M	111M	137M
Interest on Long-Term Debt	1.44M	1.47M	1.56M	-	-
Non-Cash Pension Expense	645K	264K	471K	534K	502K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	-	-	-	-
Net Rental Expense, Total	2.09M	2.39M	3.25M	4.12M	4.82M
Imputed Operating Lease Interest Expense	619K	1.06M	984K	2.67M	1.97M
Imputed Operating Lease Depreciation	1.47M	1.33M	2.26M	1.45M	2.85M
Stock-Based Comp., Other (Total)	194K	544K	536K	709K	-
Total Stock-Based Compensation	194K	544K	536K	709K	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	182M	173M	177M	176M	150M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	7.39M	1.78M	2.49M	2.5M	4.28M
Total Cash And Short Term Investments	189M	175M	180M	178M	154M
Accounts Receivable, Total	102M	107M	146M	168M	196M
Other Receivables	60.43M	61.44M	53.22M	71.99M	72.56M
Notes Receivable	5K	190K	1.05M	140K	37K
Total Receivables	162M	169M	201M	240M	269M
Inventory	211M	270M	331M	340M	404M
Prepaid Expenses	5.68M	6.82M	9.3M	9.32M	12.36M
Other Current Assets, Total	1.64M	3.95M	2.89M	3.99M	5.01M
Total Current Assets	570M	625M	724M	771M	844M
Gross Property Plant And Equipment	511M	543M	595M	644M	932M
Accumulated Depreciation	-272M	-287M	-319M	-343M	-497M
Net Property Plant And Equipment	239M	256M	275M	301M	434M
Long-term Investments	3.63M	4.08M	4.83M	4.61M	6.24M
Goodwill	135M	141M	145M	165M	277M
Other Intangibles, Total	148M	149M	154M	185M	251M
Loans Receivable Long-Term	2.48M	5.26M	5.73M	5.75M	11.14M
Deferred Tax Assets Long-Term	13.76M	22.01M	24.56M	22.32M	24.63M
Other Long-Term Assets, Total	112K	123K	118K	123K	128K
Total Assets	1.11B	1.2B	1.33B	1.46B	1.85B
Liabilities
Accounts Payable, Total	96.54M	128M	142M	133M	149M
Accrued Expenses, Total	63.96M	71.23M	74.13M	77.35M	92.72M
Short-term Borrowings	2.31M	628K	640K	2.52M	3.57M
Current Portion of Long-Term Debt	28.88M	44.99M	41.42M	44.03M	53.45M
Current Portion of Leases	7.97M	9M	9.42M	10.14M	11.55M
Current Income Taxes Payable	18.81M	22.39M	10.22M	10.27M	25.36M
Unearned Revenue Current, Total	1.48M	2.58M	1.47M	1.58M	2.22M
Other Current Liabilities	91.74M	92.33M	111M	120M	126M
Total Current Liabilities	312M	371M	391M	399M	465M
Long-Term Debt	51.67M	13.95M	18M	40.62M	218M
Long-Term Leases	26.8M	29.46M	27.39M	25M	26.55M
Unearned Revenue Non Current	1.29M	1.15M	1.85M	1.45M	1.23M
Pension & Other Post Retirement Benefits	22.13M	21.06M	18.59M	19.61M	20.36M
Deferred Tax Liability Non Current	30.34M	27.88M	25.96M	31.56M	57.23M
Other Non Current Liabilities	10.37M	12.1M	12.16M	28.53M	17.46M
Total Liabilities	454M	476M	495M	546M	805M
Common Stock, Total	10.57M	10.57M	10.57M	10.57M	10.49M
Additional Paid In Capital	6.53M	6.53M	6.53M	6.53M	6.53M
Retained Earnings	139M	114M	123M	122M	146M
Comprehensive Income and Other	467M	594M	699M	761M	880M
Total Common Equity	623M	725M	839M	900M	1.04B
Minority Interest	34.25M	256K	-351K	9.62M	286K
Total Equity	657M	725M	839M	910M	1.04B
Total Liabilities And Equity	1.11B	1.2B	1.33B	1.46B	1.85B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8.44M	8.45M	8.44M	8.37M	8.37M
ECS Total Common Shares Outstanding	8.44M	8.45M	8.44M	8.37M	8.37M
Book Value / Share	73.84	85.82	99.42	107.57	124.56
Tangible Book Value	341M	436M	540M	550M	515M
Tangible Book Value Per Share	40.36	51.57	63.94	65.69	61.53
Total Debt	118M	98.02M	96.86M	122M	313M
Net Debt	-71.65M	-76.54M	-83.01M	-56.1M	159M
Debt Equivalent of Unfunded Proj. Benefit Obligation	22.13M	21.06M	18.59M	19.61M	12.8M
Debt Equivalent Oper. Leases	16.72M	19.1M	25.98M	32.98M	38.6M
Minority Interest, Total (Incl. Fin. Div)	34.25M	256K	-351K	9.62M	286K
Equity Method Investments, Total	3.24M	3.72M	4.42M	4.24M	4.51M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	69.87M	86.75M	108M	107M	124M
Inventories - Work In Process, Total	17.08M	16.26M	25.51M	29.06M	23.75M
Inventories - Finished Goods, Total	139M	184M	220M	234M	286M
Land - (BS)	17.76M	17.89M	18.34M	27.24M	52.72M
Buildings, Total	188M	190M	208M	221M	321M
Machinery, Total	-	-	-	-	-
Full Time Employees	4.91K	5.12K	5.39K	5.46K	6.36K
Accumulated Allowance for Doubtful Accounts (Supple)	2.89M	2.25M	2.42M	2.82M	2.85M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	137M	113M	122M	121M	145M
Depreciation & Amortization - CF	33.94M	33.75M	36.03M	37.88M	46.2M
Amortization of Goodwill and Intangible Assets - (CF)	13.76M	9.59M	9.79M	9.64M	12.01M
Depreciation & Amortization, Total	47.7M	43.34M	45.82M	47.52M	58.21M
(Gain) Loss From Sale Of Asset	-73.01M	3.01M	439K	1.97M	2.45M
Asset Writedown & Restructuring Costs	24K	-1.66M	396K	-836K	-860K
(Income) Loss On Equity Investments - (CF)	-306K	-196K	-525K	-455K	-467K
Other Operating Activities, Total	19.5M	55.33M	61.11M	49.93M	73.66M
Change In Accounts Receivable	-7.63M	-5.62M	-37.84M	-22.04M	-4.89M
Change In Inventories	-22.09M	-54.26M	-55.77M	-9.03M	-20.89M
Change In Accounts Payable	12.08M	18.69M	25.44M	-9.94M	4.08M
Change In Income Taxes	-	-52.89M	-75.43M	-61.46M	-44.89M
Change in Other Net Operating Assets	7.16M	10.99M	13.37M	1.67M	-7.47M
Cash from Operations	121M	130M	98.98M	119M	204M
Capital Expenditure	-22.46M	-33.65M	-38.74M	-41.04M	-69.25M
Sale of Property, Plant, and Equipment	364M	2.91M	374K	203K	274K
Cash Acquisitions	-	-5.91M	-	-62.37M	-348M
Sale (Purchase) of Intangible assets	-8.51M	-13.52M	-14.83M	-18.86M	-11.19M
Investment in Marketable and Equity Securities, Total	4.72M	-3.16M	-1.15M	645K	2.93M
Other Investing Activities, Total	-	2.11M	-475K	-449K	-3.02M
Cash from Investing	338M	-51.21M	-54.83M	-122M	-429M
Short Term Debt Issued, Total	44.22M	46.82M	71.36M	56.05M	82.78M
Long-Term Debt Issued, Total	778K	18.82M	14.08M	32.6M	191M
Total Debt Issued	45M	65.64M	85.44M	88.65M	274M
Short Term Debt Repaid, Total	-124M	-51.6M	-87.3M	-49.42M	-86M
Long-Term Debt Repaid, Total	-258M	-35.89M	-20M	-11.23M	-15.77M
Total Debt Repaid	-383M	-87.48M	-107M	-60.64M	-102M
Issuance of Common Stock	143K	174K	-	-	-
Repurchase of Common Stock	-	-	-3.45M	-19.42M	-
Common Dividends Paid	-	-6.34M	-10.57M	-11.16M	-11.05M
Common & Preferred Stock Dividends Paid	-	-6.34M	-10.57M	-11.16M	-11.05M
Other Financing Activities, Total	-12.43M	-63.68M	1.13M	-146K	-22.22M
Cash from Financing	-350M	-91.69M	-34.76M	-2.72M	139M
Foreign Exchange Rate Adjustments	-8.83M	5.57M	-	-5.34M	939K
Miscellaneous Cash Flow Adjustments	1K	-	1K	7.98M	57.62M
Net Change in Cash	99.72M	-7.43M	9.4M	-3.32M	-27.32M
Supplemental Items
Cash Interest Paid	10.72M	5.98M	3.69M	8.88M	11.12M
Cash Income Tax Paid (Refund)	30.19M	52.89M	75.43M	61.46M	44.89M
Levered Free Cash Flow	92.43M	73.75M	34.69M	52.91M	70.46M
Unlevered Free Cash Flow	99.13M	77.49M	37M	58.46M	77.41M
Change In Net Working Capital	-4.9M	26.01M	70.58M	46.18M	43.5M
Net Debt Issued / Repaid	-338M	-21.84M	-21.86M	28.01M	172M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.35	9.24	9.06	8.34	8.66
Return on Total Capital	8.65	13.38	13.05	11.82	11.99
Return On Equity %	23.45	16.76	15.51	13.84	14.93
Return on Common Equity	24.1	16.82	15.59	13.94	14.95
Margin Analysis
Gross Profit Margin %	66.11	67	65.37	65.2	67.36
SG&A Margin	46.8	46.49	45.83	45.95	46.19
EBITDA Margin %	17.27	19.18	17.95	17.81	19.64
EBITA Margin %	14.71	16.96	15.91	15.7	17.25
EBIT Margin %	13.24	16.06	15.1	14.92	16.39
Income From Continuing Operations Margin %	15.18	10.87	9.98	9.71	10.43
Net Income Margin %	14.71	10.64	10.03	9.73	10.4
Net Avail. For Common Margin %	14.71	10.64	10.03	9.73	10.4
Normalized Net Income Margin	7.14	9.31	9.36	8.87	9.81
Levered Free Cash Flow Margin	9.89	6.93	2.85	4.24	5.04
Unlevered Free Cash Flow Margin	10.61	7.28	3.04	4.69	5.54
Asset Turnover
Asset Turnover	0.77	0.92	0.96	0.89	0.85
Fixed Assets Turnover	3.75	4.3	4.58	4.33	3.8
Receivables Turnover (Average Receivables)	9.29	10.18	9.59	7.94	7.68
Inventory Turnover (Average Inventory)	1.52	1.46	1.4	1.29	1.23
Short Term Liquidity
Current Ratio	1.83	1.68	1.85	1.93	1.82
Quick Ratio	1.13	0.93	0.97	1.05	0.91
Operating Cash Flow to Current Liabilities	0.39	0.35	0.25	0.3	0.44
Days Sales Outstanding (Average Receivables)	39.39	35.86	38.06	46	47.68
Days Outstanding Inventory (Average Inventory)	241.36	250.2	260.51	282.06	298.43
Average Days Payable Outstanding	106.35	99.67	98.24	113.66	99.33
Cash Conversion Cycle (Average Days)	174.4	186.39	200.34	214.4	246.79
Long Term Solvency
Total Debt/Equity	17.9	13.52	11.54	13.44	29.98
Total Debt / Total Capital	15.18	11.91	10.35	11.85	23.07
LT Debt/Equity	11.94	5.99	5.41	7.21	23.41
Long-Term Debt / Total Capital	10.13	5.27	4.85	6.36	18.01
Total Liabilities / Total Assets	40.87	39.65	37.08	37.49	43.55
EBIT / Interest Expense	11.54	28.56	49.77	20.95	20.6
EBITDA / Interest Expense	15.99	35.8	62.18	26.3	25.83
(EBITDA - Capex) / Interest Expense	13.9	30.18	51.68	21.68	19.61
Total Debt / EBITDA	0.69	0.46	0.42	0.52	1.09
Net Debt / EBITDA	-0.42	-0.36	-0.36	-0.24	0.55
Total Debt / (EBITDA - Capex)	0.79	0.54	0.51	0.64	1.44
Net Debt / (EBITDA - Capex)	-0.48	-0.42	-0.44	-0.29	0.73
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.44	13.89	14.31	2.53	12.07
Gross Profit, 1 Yr. Growth %	-0.96	15.43	12.79	2.27	15.77
EBITDA, 1 Yr. Growth %	8.22	28.05	7.82	1.72	23.06
EBITA, 1 Yr. Growth %	9.9	33.18	8.19	1.17	23.15
EBIT, 1 Yr. Growth %	18	40.28	8.54	1.31	23.07
Earnings From Cont. Operations, 1 Yr. Growth %	160.5	-17.57	4.86	-0.17	20.39
Net Income, 1 Yr. Growth %	166.66	-16.82	7.78	-0.53	19.78
Normalized Net Income, 1 Yr. Growth %	33.16	51.25	16.13	-2.82	23.94
Diluted EPS Before Extra, 1 Yr. Growth %	166.61	-16.9	7.85	-0.28	20.58
Accounts Receivable, 1 Yr. Growth %	2.32	5.58	36.25	14.82	16.73
Inventory, 1 Yr. Growth %	2.16	28.1	22.41	2.65	18.99
Net Property, Plant and Equip., 1 Yr. Growth %	-7.53	7.16	7.46	9.34	44.34
Total Assets, 1 Yr. Growth %	-16.01	8.3	10.98	9.16	26.98
Tangible Book Value, 1 Yr. Growth %	-606.5	27.78	23.91	1.79	-6.29
Common Equity, 1 Yr. Growth %	20.31	16.74	15.78	7.22	15.86
Cash From Operations, 1 Yr. Growth %	-8.14	9.24	-23.8	19.86	72.13
Capital Expenditures, 1 Yr. Growth %	34.34	49.84	15.13	5.93	68.72
Levered Free Cash Flow, 1 Yr. Growth %	-6.12	-20.67	-51.95	54.89	32.61
Unlevered Free Cash Flow, 1 Yr. Growth %	-9.54	-22.25	-51.28	60.32	31.91
Dividend Per Share, 1 Yr. Growth %	-	66.67	5.6	0	9.85
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.69	6.48	14.1	8.26	7.19
Gross Profit, 2 Yr. CAGR %	3.67	6.92	13.46	7.4	8.81
EBITDA, 2 Yr. CAGR %	17.05	16.99	17.04	4.73	12.12
EBITA, 2 Yr. CAGR %	20.53	20.11	19.5	4.62	11.62
EBIT, 2 Yr. CAGR %	28.4	27.66	22.81	4.86	11.66
Earnings From Cont. Operations, 2 Yr. CAGR %	159.92	45.8	-7.02	2.31	9.63
Net Income, 2 Yr. CAGR %	161.52	48.16	-5.31	3.53	9.15
Normalized Net Income, 2 Yr. CAGR %	46.12	40.64	31.86	6.23	9.75
Diluted EPS Before Extra, 2 Yr. CAGR %	161.27	48.07	-5.39	3.67	9.66
Accounts Receivable, 2 Yr. CAGR %	0.09	3.94	19.94	25.08	15.77
Inventory, 2 Yr. CAGR %	3.82	14.39	25.22	12.09	10.52
Net Property, Plant and Equip., 2 Yr. CAGR %	0.55	-0.52	7.31	8.4	25.63
Total Assets, 2 Yr. CAGR %	-6.55	-4.71	9.63	10.07	17.73
Tangible Book Value, 2 Yr. CAGR %	53.56	154.55	25.83	12.34	-2.33
Common Equity, 2 Yr. CAGR %	16.33	18.32	16.26	11.44	11.46
Cash From Operations, 2 Yr. CAGR %	20.24	-0.65	-8.77	-4.43	43.64
Capital Expenditures, 2 Yr. CAGR %	-6.74	41.88	31.34	10.44	33.69
Levered Free Cash Flow, 2 Yr. CAGR %	51.43	-13.46	-38.91	-14.4	43.63
Unlevered Free Cash Flow, 2 Yr. CAGR %	38.83	-15.91	-39.07	-12.26	45.7
Dividend Per Share, 2 Yr. CAGR %	-	-	32.66	2.76	4.81
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.72	6.98	9.03	10.1	9.51
Gross Profit, 3 Yr. CAGR %	3.41	7.45	8.43	9.6	10.12
EBITDA, 3 Yr. CAGR %	14.55	20.11	13.56	11.7	10.67
EBITA, 3 Yr. CAGR %	17.4	24	15.65	13.05	10.46
EBIT, 3 Yr. CAGR %	23.97	31.56	20.56	15.18	10.61
Earnings From Cont. Operations, 3 Yr. CAGR %	331.96	76.66	30.63	-4.8	8.01
Net Income, 3 Yr. CAGR %	276.53	77.9	33.25	-3.75	8.69
Normalized Net Income, 3 Yr. CAGR %	37.6	46.92	31.5	19.11	11.84
Diluted EPS Before Extra, 3 Yr. CAGR %	274.56	77.72	33.17	-3.74	9.03
Accounts Receivable, 3 Yr. CAGR %	-3.44	1.89	13.75	18.21	22.23
Inventory, 3 Yr. CAGR %	4.53	11.36	17.01	17.19	14.35
Net Property, Plant and Equip., 3 Yr. CAGR %	0.07	2.67	2.07	7.98	19.26
Total Assets, 3 Yr. CAGR %	-4.53	-1.9	0.26	9.48	15.44
Tangible Book Value, 3 Yr. CAGR %	23.45	44.49	100.24	17.27	5.75
Common Equity, 3 Yr. CAGR %	12.6	16.35	17.47	13.18	12.9
Cash From Operations, 3 Yr. CAGR %	3.89	15.82	-9.06	-0.08	16.28
Capital Expenditures, 3 Yr. CAGR %	-10.7	9.23	32.34	22.26	27.19
Levered Free Cash Flow, 3 Yr. CAGR %	15.39	22.3	-29.37	-17.13	-0.81
Unlevered Free Cash Flow, 3 Yr. CAGR %	10.81	14.64	-30.37	-16.29	0.64
Dividend Per Share, 3 Yr. CAGR %	-	-	-	20.74	5.07
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.84	4.06	7.13	7.49	8.29
Gross Profit, 5 Yr. CAGR %	2.17	4.51	7.32	7.19	8.58
EBITDA, 5 Yr. CAGR %	13.76	13.26	15.25	13.53	12.98
EBITA, 5 Yr. CAGR %	17	15.56	17.89	15.65	14.02
EBIT, 5 Yr. CAGR %	26.04	20.83	23.12	19.92	16.92
Earnings From Cont. Operations, 5 Yr. CAGR %	62.1	25.03	133.2	41.98	21.78
Net Income, 5 Yr. CAGR %	70.99	26.71	116.32	43.26	23.03
Normalized Net Income, 5 Yr. CAGR %	50.63	28.63	34.79	28.79	22.32
Diluted EPS Before Extra, 5 Yr. CAGR %	70.95	26.66	115.57	43.22	23.2
Accounts Receivable, 5 Yr. CAGR %	-7.59	-3.63	5.31	10.6	14.56
Inventory, 5 Yr. CAGR %	2.97	6.44	12.36	11.65	14.37
Net Property, Plant and Equip., 5 Yr. CAGR %	0.88	0.74	2.88	4.92	10.91
Total Assets, 5 Yr. CAGR %	-4.92	-3.25	0.86	2.72	6.91
Tangible Book Value, 5 Yr. CAGR %	6.72	14.32	24.42	30.65	50.27
Common Equity, 5 Yr. CAGR %	7.28	8.89	13.98	14.36	15.04
Cash From Operations, 5 Yr. CAGR %	21.2	-1.83	-1.69	7.25	9.18
Capital Expenditures, 5 Yr. CAGR %	-9.51	-0.43	4.2	9.71	32.88
Levered Free Cash Flow, 5 Yr. CAGR %	35	-3.14	-10.42	5.59	-6.47
Unlevered Free Cash Flow, 5 Yr. CAGR %	53.89	-4.8	-12.67	2.59	-6.72